0001802806-23-000007.txt : 20230818 0001802806-23-000007.hdr.sgml : 20230818 20230818160344 ACCESSION NUMBER: 0001802806-23-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 EFFECTIVENESS DATE: 20230818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ikena Oncology, Inc. CENTRAL INDEX KEY: 0001835579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490181 FILM NUMBER: 231185849 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-343-8292 MAIL ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 D 1 primary_doc.xml X0708 D LIVE 0001835579 Ikena Oncology, Inc. 645 Summer Street, Suite 101 BOSTON MA MASSACHUSETTS 02210 857-273-8343 DELAWARE None None Corporation true Mark Manfredi c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Executive Officer Director Jeffrey Ecsedy c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Executive Officer Jotin Marango c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Executive Officer Sergio Santillana c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Executive Officer Michelle Zhang c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Executive Officer Owen Hughes c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director David Bonita c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director Iain D. Dukes c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director Jean-Francois Formela c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director Maria Koehler c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director Otello Stampacchia c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director Richard Wooster c/o Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA MASSACHUSETTS 02210 Director Pharmaceuticals Decline to Disclose 06b false 2023-08-04 false true true Issuance of shares pursuant to Agreement and Plan of Merger, dated August 4, 2023, by and among the Issuer, Portsmouth Merger Sub I, Inc., Portsmouth Merger Sub II, LLC, Pionyr Immunotherapeutics, Inc., and Fortis Advisors LLC. 0 42571751 42571751 0 false 48 0 0 0 false Ikena Oncology, Inc. /s/ Jotin Marango Jotin Marango CFO 2023-08-18